Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered-Dose Inhaler (pMDI) in Subjects with Chronic Obstructive Pulmonary Disease (COPD) on Cardiovascular Parameters: Results from the GLIMMER Study

被引：0

作者：

Kerwin, E. M. ^{[1
]}

Feldman, G. ^{[2
]}

Beaudot, C. ^{[3
]}

Georges, G. ^{[4
]}

机构：

[1] Clin Res Inst, Medford, OR USA

[2] South Carolina Pharmaceut Res, Spartanburg, SC USA

[3] Chiesi USA Inc, Cary, NC USA

[4] Chiesi USA, Global Clin Dev, Cary, NC USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A7371

引用

页数：2

共 45 条

[1] Dose-Ranging Effects of Glycopyrronium Bromide (GB) Delivered Via a Pressurized Metered Dose-Inhaler (pMDI) on Lung Function in Subjects with Chronic Obstructive Pulmonary Disease (COPD): The GLIMMER Study
Pearle, J.
Kerwin, E. M.
Delacruz, L.
Beaudot, C.
Edwards, M.
Georges, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[2] Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Chronic Obstructive Pulmonary Disease
Lyseng-Williamson, Katherine A.
DRUGS, 2009, 69 (11) : 1459 - 1470
[3] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Symptoms of Chronic Obstructive Pulmonary Disease (COPD) in Patients with Moderate to Very Severe COPD
Tashkin, D. P.
Rennard, S. I.
Ramachandran, S.
Martin, P.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[4] BRONCHODILATOR REVERSIBILITY AND ONSET WITH BUDESONID/FORMOTEROL PRESSURIZED METERED-DOSE INHALER (BUD/FM PMDI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Celli, B. R.
Tashkin, D. P.
Rennard, S. I.
McElhattan, J.
Martin, U. J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A61 - A61
[5] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Pulmonary Function in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD).
Tashkin, D. P.
Rennard, S. I.
McElhattan, J.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[6] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Exacerbations in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Rennard, S. I.
Tashkin, D. P.
Martin, P.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[7] Pharmacokinetics of the Extrafine Fixed-Dose Combination of Beclomethasone Dipropionate, Formoterol Fumarate, Glycopyrronium Bromide Delivered Via a Pressurized-Metered Dose Inhaler (pMDI) in Chinese Subjects
Georges, G.
Luo, Z.
Ciurlia, G.
Guller, P.
Girardello, L.
Mariotti, F.
Poli, G.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[8] Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease
Drugs & Therapy Perspectives, 2010, 26 (11) : 6 - 9
[9] Formoterol/budesonide pressurized metered-dose inhaler: A guide to its use in chronic obstructive pulmonary disease
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2014, 30 (8) : 269 - 275
[10] Dose-Ranging Effects of Extrafine Beclomethasone Dipropionate (BDP) Delivered Via a Pressurized Metered-Dose Inhaler (PMDI) in Patients with Asthma: The Beam Study
Vandewalker, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201

← 1 2 3 4 5 →